Why Is Regeneron Stock Sinking Monday?

On Friday, Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) reviewed results from the Phase 3 trial evaluating two dose levels of fianlimab (LAG-3 inhibitor) in combination with Libtayo (cemiplimab) for unresectable locally advanced or metastatic melanoma. Phase 3...

Why Is NextNRG Stock Soaring Monday?

NextNRG, Inc. (NASDAQ:NXXT) shares surged in Monday premarket trading after the company reported first-quarter results that topped Wall Street estimates. Earnings Snapshot Revenue rose 29% year over year to $21.1 million, exceeding the analyst consensus estimate of...